Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

Phase 3

Active, not recruiting

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Drug: N-acetyl cysteine
Drug: Placebo

First Posted Date: 2020-03-09

Last Posted Date: 2025-05-29

Lead Sponsor: Fernando J Martinez

Target Recruit Count: 202

Registration Number: NCT04300920

Locations: 🇺🇸
Piedmont Healthcare, Austell, Georgia, United States
🇺🇸
Loyola University, Maywood, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

and more 22 locations

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Phase 2

Not yet recruiting

Conditions: Meningioma

Interventions: Drug: Ga-68- DOTATATE
Drug: Ga-68-DOTATOC

First Posted Date: 2020-03-06

Last Posted Date: 2025-05-16

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 6

Registration Number: NCT04298541

Locations: 🇺🇸
Weill Cornell Medical College of Cornell University, New York, New York, United States

Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region

Not Applicable

Completed

Conditions: TMJ Disorder
Myofacial Pain
TMD

Interventions: Other: CBD Oil
Other: Hemp Oil

First Posted Date: 2020-03-06

Last Posted Date: 2023-03-14

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 59

Registration Number: NCT04298554

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

pCHIP: Prostate Cancer Health Impact Program

Terminated

Conditions: Prostate Cancer

Interventions: Other: Decision Navigation Intervention (DNI)

First Posted Date: 2020-03-03

Last Posted Date: 2024-07-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 82

Registration Number: NCT04293406

Locations: 🇺🇸
New York-Presbyterian Queens, Fresh Meadows, New York, United States
🇺🇸
New York-Presbyterian Brooklyn Methodist, Brooklyn, New York, United States

A Behavioral Intervention for Depression and Chronic Pain in Primary Care (Relief-Hybrid)

Not Applicable

Withdrawn

Conditions: Chronic Pain
Depression

Interventions: Behavioral: Relief-Hybrid

First Posted Date: 2020-03-02

Last Posted Date: 2023-03-24

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT04290845

Locations: 🇺🇸
Irving Sherwood Wright Center, New York, New York, United States
🇺🇸
Weill Cornell Internal Medical Associates (WCIMA), New York, New York, United States
🇺🇸
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, New York, United States

and more 1 locations

Reaching and Engaging Depressed Senior Center Clients

Not Applicable

Completed

Conditions: Depression in Old Age

Interventions: Other: Training and utilizing Engage-A therapy
Behavioral: Engage-A

First Posted Date: 2020-02-28

Last Posted Date: 2023-08-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 26

Registration Number: NCT04289298

Locations: 🇺🇸
Weill Cornell Medicine, White Plains, New York, United States

Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis

Completed

Conditions: Extrinsic Allergic Alveolitis
Interstitial Lung Disease
Health-related Quality of Life
Hypersensitivity Pneumonitis
Chronic Hypersensitivity Pneumonitis

Interventions: Other: Chronic Hypersensitivity Pneumonitis Health Related Quality of Life Survey Instrument

First Posted Date: 2020-02-18

Last Posted Date: 2023-07-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 60

Registration Number: NCT04273867

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

Phase 2

Active, not recruiting

Conditions: AL Amyloidosis
Amyloid
Refractory AL Amyloidosis

Interventions: Drug: Daratumumab SC
Drug: Pomalidomide
Drug: Dexamethasone

First Posted Date: 2020-02-17

Last Posted Date: 2025-05-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT04270175

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
Boston University Medical Center, Boston, Massachusetts, United States
🇺🇸
Weill Cornell Medicine - Multiple Myeloma Center, New York, New York, United States

and more 1 locations

The Impact of Time Restricted Feeding in Crohn's Disease

Not Applicable

Completed

Conditions: Crohn's Disease (CD)

Interventions: Other: Time Restricted Feeding

First Posted Date: 2020-02-17

Last Posted Date: 2023-01-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT04271748

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Adaptation of Ca-HELP Intervention in Rural Geriatric Cancer Patient Population

Not Applicable

Completed

Conditions: Pain

Interventions: Behavioral: Adapted Ca-HELP for Geriatric Cancer Patients

First Posted Date: 2020-02-10

Last Posted Date: 2023-03-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 30

Registration Number: NCT04262232

Locations: 🇺🇸
Maury Regional Medical Center, Columbia, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy